Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997

BACKGROUND: Drug repurposing (i.e., finding novel uses for existing drugs) is essential for maximizing medicines’ therapeutic utility, but obtaining regulatory approval for new indications is costly. Policymakers have therefore created temporary indication-specific market exclusivities to incentiviz...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pharm Policy Pract
Asıl Yazarlar: Sahragardjoonegani, Babak, Beall, Reed F., Kesselheim, Aaron S., Hollis, Aidan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2021
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780607/
https://ncbi.nlm.nih.gov/pubmed/33397471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-020-00282-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller